Prevention of cardiovascular diseases
EFSA endorses the cardioprotective capacity of Hydroxytyrosol that also inhibits platelet aggregation that takes place in thrombosis and protects cells from cell death induced by reactive oxygen intermediates, as occurs in situations of ischemia.
Anti-inflammatory
Hydroxytyrosol has been shown to inhibit the production of pro-inflammatory compounds caused by human leukocytes such as leukotrienes.
Anti-aging
The antioxidant capacity of Hydroxytyrosol delays the cellular aging processes and premature aging.
Antimicrobial
It contains powerful antimicrobial properties against various types of bacteria, viruses and fungi.
Anticancer
Hydroxytyrosol prevents DNA damage induced by different genotoxic species and induces apoptosis (cell death) in different tumor lines, such as breast and colon cancer.
Protection against harmful UV radiation
Hydroxytyrosol has a capacity to prevent damage caused to melanoma cells when exposed to harmful UV radiation.
Prevention of neurodegenerative diseases
Several studies suggest that reactive oxygen species are involved in the etiology of a series of degenerative diseases such as cardiovascular diseases, diabetes, cancer, and Alzheimer’s. Hydroxytyrosol exerts antioxidant protection against oxidative damage induced by various types of reactive oxygen and nitrogen species in nervous tissues.
Protection against AMD
(Age-Related Macular Degeneration). This is a disease related to age and other harmful lifestyle effects such as tobacco, which causes blindness in people over 55 years. Hydroxytyrosol has antioxidant, anti-inflammatory and protective properties of the pigment epithelium, which minimize its appearance and development.
